Literature DB >> 22330700

Maintenance electroconvulsive therapy (M-ECT) after acute response: examining the evidence for who, what, when, and how?

Kiran Rabheru1.   

Abstract

OBJECTIVE: To examine the evidence for maintenance electroconvulsive therapy (M-ECT) to help determine who, when, and how long ECT should be continued.
METHOD: A review of published literature on the use of maintenance ECT (M-ECT) was conducted. It focused primarily on trials published since 1997, meeting the following additional criteria: randomized controlled trial or cohort study with a comparison (matched group or before and after), and at least 10 patients receiving M-/continuation ECT. Where such data are not available, recent case series were reviewed.
RESULTS: Relapse rates after discontinuation of ECT are very high. Maintenance ECT is an underused treatment option that can substantially reduce risks of relapse in patients with major depressive disorder and likely in bipolar disorder and schizophrenia as well. Little data are available for the use of M-ECT in neurological disorders, and no cost-effectiveness analyses in the maintenance setting were found.
CONCLUSIONS: Whereas no clear answers emerge from the literature, there is now a growing body of evidence to suggest that for those who have not responded well to medications but have responded to ECT, M-ECT must be presented as an option to the patient and the family for consideration. Clear consensus guidelines for the use of M-ECT are needed.

Entities:  

Mesh:

Year:  2012        PMID: 22330700     DOI: 10.1097/YCT.0b013e3182455758

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  11 in total

1.  Electroconvulsive therapy: a life course approach for recurrent depressive disorder.

Authors:  Sarah Carney; Musa Basseer Sami; Victoria Clark; Kompancariel Kuruvilla Kuruvilla
Journal:  BMJ Case Rep       Date:  2015-05-24

Review 2.  Economic evidence for the clinical management of major depressive disorder: a systematic review and quality appraisal of economic evaluations alongside randomised controlled trials.

Authors:  E Karyotaki; D Tordrup; C Buntrock; R Bertollini; P Cuijpers
Journal:  Epidemiol Psychiatr Sci       Date:  2016-06-22       Impact factor: 6.892

Review 3.  Relapse prevention after index electroconvulsive therapy in treatment-resistant depression.

Authors:  Nagy A Youssef; W Vaughn McCall
Journal:  Ann Clin Psychiatry       Date:  2014-11       Impact factor: 1.567

Review 4.  On the significance of electroconvulsive therapy in the treatment of severe mental diseases.

Authors:  Michael Grözinger; Elke Stefanie Smith; Andreas Conca
Journal:  Wien Klin Wochenschr       Date:  2015-03-03       Impact factor: 1.704

5.  Electroconvulsive Therapy Practice in the Province of Quebec: Linked Health Administrative Data Study from 1996 to 2013.

Authors:  Morgane Lemasson; Julie Haesebaert; Louis Rochette; Eric Pelletier; Alain Lesage; Simon Patry
Journal:  Can J Psychiatry       Date:  2017-10-25       Impact factor: 4.356

6.  [Efficacy of continuation and maintenance electroconvulsive therapy (c/m ECT) in the treatment of patients with therapy-resistant affective disorders: a retrospective analysis].

Authors:  Thomas Post; Georg Kemmler; Tristan Krassnig; Anita Brugger; Armand Hausmann
Journal:  Neuropsychiatr       Date:  2015-06-20

7.  Current clinical practice of electroconvulsive therapy and repetitive transcranial magnetic stimulation in psychiatry, a German sample.

Authors:  Charles Timäus; Jonathan Vogelgsang; Bernhard Kis; Katrin Radenbach; Claus Wolff-Menzler; Kiriaki Mavridou; Stephan Gyßer; Philipp Hessmann; Jens Wiltfang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-01-29       Impact factor: 5.270

8.  Clinical Effectiveness of Maintenance Electroconvulsive Therapy in Patients with Schizophrenia: A Retrospective Cohort Study.

Authors:  Moshe Isserles; Jesse Remington; Tyler S Kaster; Zafiris J Daskalakis; Daniel M Blumberger
Journal:  J ECT       Date:  2020-03       Impact factor: 3.692

9.  Patients with schizophrenia or schizoaffective disorder who receive multiple electroconvulsive therapy sessions: characteristics, indications, and results.

Authors:  Iulian Iancu; Nimrod Pick; Orit Seener-Lorsh; Pinhas Dannon
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-27       Impact factor: 2.570

10.  Shared preventive factors associated with relapse after a response to electroconvulsive therapy in four major psychiatric disorders.

Authors:  Wataru Omori; Kei Itagaki; Naoto Kajitani; Hiromi Abe; Mami Okada-Tsuchioka; Yasumasa Okamoto; Minoru Takebayashi
Journal:  Psychiatry Clin Neurosci       Date:  2019-06-01       Impact factor: 5.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.